You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Seattle, Washington 98109

  • Ovarian Ca

Purpose:

RATIONALE: Understanding the emotional needs of spouses or others who are living with and caring for patients who have undergone stem cell transplantation may help improve the quality of life of both the caregivers and the patients. PURPOSE: This clinical trial is studying the emotional needs of caregivers of patients who have undergone stem cell transplant.


Study summary:

OBJECTIVES: - Assess expression of emotion, as a function of patient presence, among spousal or other cohabiting caregivers (CG) of post-hematopoietic stem cell transplantation patients. - Assess desynchrony among subjective (self-report) and expressive indicators of emotion, as a function of patient presence, in these participants. - Correlate CG dispositional inhibition and desynchrony with physical and marital satisfaction in these participants. OUTLINE: Caregivers (CG) complete written questionnaires assessing demographics, positive and negative affect, dispositional inhibition, marital satisfaction, and physical health over 45 minutes to 1 hour on day 1. CG then engage in two oral emotional expression exercises (on the topic of caregiving and the transplant) over 2 hours on day 2. Patients are present for one oral emotional expression exercise. Participants are followed at 2 weeks and 6 months. PROJECTED ACCRUAL: A total of 60 patient/spouse couples will be accrued for this study within 18 months.


Criteria:

DISEASE CHARACTERISTICS: - In a marriage OR long-term, committed, heterosexual or homosexual, cohabiting relationship in which one member is post-hematopoietic stem cell transplantation - Patients must meet the following criteria: - At least 1 year since prior first bone marrow, stem cell, or umbilical cord blood transplantation - Allogeneic or autologous - Diagnosis of malignancy, myelodysplasia, or non-malignancy - No indication of possible or confirmed relapse - Spouse/caregiver (CG) must meet the following criteria: - Serve as the primary CG to the patient - No prior or concurrent neurologic disorder PATIENT CHARACTERISTICS: Age - 21 and over Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - No concurrent major psychiatric disorder - English-speaking PRIOR CONCURRENT THERAPY: Biologic therapy - See Disease Characteristics Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified


NCT ID:

NCT00082654


Primary Contact:

Principal Investigator
Shelby Langer, PhD
Fred Hutchinson Cancer Research Center


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98109
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.